ArticleCancers2023

A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy.

Laura Marconato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.